Fitbit has completed clinical trials of its own ECG feature and is looking to get FDA approval – as it launches a large scale study into Afib and irregular heart rate detection. The mass Fitbit Heart ...
Even minor ECG abnormalities detected with annual checks signal a greater risk of future CVD events, a study of several million working-age people affirms, although questions remain about whether ...
HeartBeam’s synthesised 12-lead electrocardiogram (ECG) has met the clinical endpoints in the VALID-ECG pivotal study, assessing non-life-threatening arrhythmias. In the study, the mean difference in ...
Please provide your email address to receive an email when new articles are posted on . Abnormal ECG findings were rare in elite female basketball players. These data may serve as a reference for ...
(NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, ...
Can atrial fibrillation and atrial flutter be accurately detected using a smartphone-operated single-lead electrocardiography device? A smartphone-operated, single-lead electrocardiography (1L-ECG) ...
(RTTNews) - HeartBeam, Inc., (BEAT), a medical technology company, Tuesday said its synthesized 12-lead electrocardiogram (ECG) met the clinical endpoints in the VALID-ECG pivotal study. The study ...
A take-home wearable ECG could be key in detecting undiagnosed atrial fibrillation, according to a new study published in JAMA this morning. Researchers from The Scripps Research Institute used the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results